Fennec Pharmaceuticals (FENC) Gross Profit (QoQ) (2023 - 2025)

Fennec Pharmaceuticals (FENC) Gross Profit (QoQ) (2023 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,583.17 Bn 67,582.89 Bn -
2 Nanobiotix 1,947.22 Bn 1,947.15 Bn -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn -
4 BeOne Medicines 473.21 Bn 468.42 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.29 Bn 116.04 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.05 Bn 61.29 Bn 3.31 Bn
7 Belite Bio 63.09 Bn 63.09 Bn -
8 Argenx Se 56.63 Bn 51.45 Bn 1.41 Bn
9 Revolution Medicines 37.79 Bn 37.79 Bn -
10 Fennec Pharmaceuticals 293.63 Mn 256.84 Mn 12.01 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.79%
Sep 30, 2025 35.89%
Jun 30, 2025 3.66%
Mar 31, 2025 15.46%
Dec 31, 2024 29.18%
Sep 30, 2024 -15.58%
Jun 30, 2024 -73.20%
Mar 31, 2024 174.33%
Dec 31, 2023 46.35%
Sep 30, 2023 94.65%
Jun 30, 2023 100.82%